Skip to content
Tenfell
Awarded contract
Published 12 Jun 2020

Proprietary Drugs 2

Velindre NHS Trust; NHS Wales Shared Services Partnership — Procurement Services · United Kingdom

Key facts

Contract value
€111,561,107
Awarded
11 Jun 2020
Contract starts
01 Jul 2020
Contract ends
30 Jun 2022
Procedure
Open procedure
Buyer type
Health

Awarded to 44 suppliers

SupplierValue
Abbvie Ltd—
Accord-UK Ltd—
Acre Pharma Limited—
Alliance Pharmaceuticals Ltd—
Amgen Ltd—
Bayer plc—
Bristol-Myers Squibb Pharmaceuticals Ltd—
Celgene Ltd—
Cheplapharm Arzneimittel GmbH—
Chiesi Limited—
Consilient Health Ltd—
Correvio GmbH—
Dr Reddy's Laboratories (UK) Ltd—
Eli Lilly & Company Ltd—
FERRING LTD—
Galen Ltd—
Gilead Sciences Limited—
Glenmark Pharmaceuticals—
Intrapharm Laboratories Ltd—
Ipsen—
Janssen Limited—
Lupin Healthcare UK Ltd—
Martindale—
Merck Sharp & Dohme UK Ltd—
Mercury Pharmaceuticals Limited—
NAPP PHARMACEUTICAL GROUP LIMITED—
Novartis Pharmaceuticals UK Ltd—
Novo Nordisk Pharmaceuticals Ltd—
Orion Pharma (UK) Ltd—
Pfizer Ltd—
Pharmasure—
Rayner Pharmaceuticals Ltd—
Roche Products Ltd—
Sandoz Ltd—
Sanofi—
Shire Pharmaceuticals Limited—
Takeda UK Limited—
Teva UK Ltd—
Theramex—
Thornton & Ross Ltd—
Typharm Ltd—
UCB Pharma Ltd—
UPJOHN UK LIMITED—
Zentiva Pharma UK Ltd—

Categories (CPV)

Similar open tenders

About Velindre NHS Trust; NHS Wales Shared Services Partnership — Procurement Services

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Published by the buyer on TED archive (UK notices before Brexit) (EU open data (Decision 2011/833/EU)). Always read the original notice before responding.